Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/28740
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarros, Maria A.pt_PT
dc.contributor.authorAlmeida, Mafalda R.pt_PT
dc.contributor.authorFaria, Joaquim L.pt_PT
dc.contributor.authorSampaio, Maria J.pt_PT
dc.contributor.authorTavares, Ana P. M.pt_PT
dc.contributor.authorSilva, Cláudia G.pt_PT
dc.date.accessioned2020-06-29T14:27:37Z-
dc.date.available2020-06-29T14:27:37Z-
dc.date.issued2019-06-
dc.identifier.urihttp://hdl.handle.net/10773/28740-
dc.description.abstractBiopharmaceuticals have been used to overcome fatal diseases related with aging. L-aspariginase (LA), in particular, has shown evidences of being efficient for leukemia therapy. The LA production and purification require several steps increasing the cost of the process. In this work, functionalized carbon nanotubes (CNTs) were studied as a cost-effective support to purify LA. It was shown that CNTs have strong affinity for the target biopharmaceutical, meaning that can be a promising alternative for the adsorption and purification of LA.pt_PT
dc.language.isoengpt_PT
dc.relationUID/EQU/50020/2019pt_PT
dc.relationPOCI-01-0145-FEDER- 031268pt_PT
dc.relationPOCI-01-0145-FEDER-030674pt_PT
dc.relationIF/00514/2014pt_PT
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectCarbon nanotubespt_PT
dc.subjectAntileukemic drugspt_PT
dc.subjectL-asparaginasept_PT
dc.subjectPurificationpt_PT
dc.titleTailoring carbon nanotubes surface chemistry for the purification of antileukemic drugspt_PT
dc.typeconferenceObjectpt_PT
dc.description.versionpublishedpt_PT
dc.peerreviewedyespt_PT
ua.event.date27-28, junho, 2019pt_PT
degois.publication.title3rd Doctoral Congress in Engineeringpt_PT
Appears in Collections:CICECO - Comunicações

Files in This Item:
File Description SizeFormat 
DCE_abstract_MAB.pdf179.95 kBAdobe PDFView/Open


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.